Corticotropin-releasing hormone receptor type 1 (CRHR1) genetic variation and stress interact to influence reward learning.
J. Neurosci., Sep;31(37):13246-54 (2011)
Risks for the transition from major depressive disorder to bipolar disorder in the National Epidemiologic Survey on Alcohol and Related Conditions.
J Clin Psychiatry., Jun;73(6):829-36 (2012)
A critical review of pharmacotherapy for major depressive disorder.
Int. J. Neuropsychopharmacol., Nov;14(10):1417-31 (2011)
Can single genes matter in a polygenic world?
Biol. Psychiatry., Nov;68(9):783-4 (2010)
Genome-wide association study of suicide attempts in mood disorder patients.
Am J Psychiatry., Dec;167(12):1499-507 (2010)
Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.
Arch. Gen. Psychiatry., Apr;68(4):351-60 (2011)
Translating biomarkers to clinical practice.
Mol. Psychiatry., Nov;16(11):1076-87 (2011)
Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study.
J Clin Psychiatry., Mar;71(3):296-303 (2010)
Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder.
Am J Psychiatry., May;167(5):574-9 (2010)
The impact of mineralocorticoid receptor ISO/VAL genotype (rs5522) and stress on reward learning.
Genes Brain Behav., Aug;9(6):658-67 (2010)
Neuroleptic malignant syndrome: further lessons from a case report.
Psychosomatics., 51(4):349-54 (2010)
Transition to mania during treatment of bipolar depression.
Neuropsychopharmacology., Dec;35(13):2545-52 (2010)
Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.
Am J Psychiatry., Oct;167(10):1254-63 (2010)
Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.
Biol. Psychiatry., May;65(9):785-91 (2009)
Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder.
Acta Psychiatr Scand., Apr;119(4):282-9 (2009)
When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study.
Neuropsychopharmacology., Sep;34(10):2227-36 (2009)
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.
Bipolar Disord., Jun;11(4):391-400 (2009)
Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans.
Hum Brain Mapp., Feb;31(2):210-21 (2010)
Cigarette smoking is associated with suicidality in bipolar disorder.
Bipolar Disord., Nov;11(7):766-71 (2009)
Stability of symptoms across major depressive episodes in bipolar disorder.
Bipolar Disord., Dec;11(8):867-75 (2009)
Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study.
Arch. Intern. Med., Dec;169(22):2128-39 (2009)
Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.
J Clin Psychiatry., May;71(5):599-605 (2010)
Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report.
J Clin Psychiatry., Feb;71(2):194-200 (2010)
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
Arch. Gen. Psychiatry., Jun;64(6):689-97 (2007)
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.
Neuropsychopharmacology., Nov;33(12):2810-9 (2008)
Antidepressant dose reduction and the risk of relapse in major depressive disorder.
Psychother Psychosom., 76(5):266-70 (2007)
Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
Am J Manag Care., Nov;13(7 Suppl):S178-88 (2007)
Family-based association study of lithium-related and other candidate genes in bipolar disorder.
Arch. Gen. Psychiatry., Jan;65(1):53-61 (2008)
Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task.
Biol. Psychiatry., Jul;64(2):162-8 (2008)
Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder.
Acta Psychiatr Scand., Apr;117(4):271-6 (2008)
A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder.
J. Occup. Environ. Med., Apr;50(4):428-36 (2008)
Personality disorders and perceived stress in major depressive disorder.
Psychiatry Res., Aug;160(2):184-91 (2008)
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.
Nat. Genet., Sep;40(9):1056-8 (2008)
Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse?
Neuron., Oct;60(1):174-88 (2008)
Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes.
Psychother Psychosom., 76(1):40-6 (2007)
The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder.
J Clin Psychiatry., Dec;67(12):1907-11 (2006)
Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
J Clin Psychiatry., Nov;67(11):1747-53 (2006)
Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications.
J Clin Psychiatry., Jan;68(1):52-7 (2007)
Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians.
Curr Med Res Opin., Mar;23(3):467-75 (2007)
Pharmacogenetic studies of antidepressant response: how far from the clinic?
Psychiatr. Clin. North Am., Mar;30(1):125-38 (2007)
Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder.
Am. J. Med. Genet. B Neuropsychiatr. Genet., Sep;144B(6):781-90 (2007)
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Am J Psychiatry., Feb;163(2):217-24 (2006)
Clinical features of bipolar depression versus major depressive disorder in large multicenter trials.
Am J Psychiatry., Feb;163(2):225-31 (2006)
Brain white-matter hyperintensities and treatment outcome in major depressive disorder.
Br J Psychiatry., Feb;188:180-5 (2006)
Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.
J Clin Psychiatry., Apr;67(4):509-16 (2006)
The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry.
J Clin Psychiatry., 67 Suppl 11:3-7 (2006)
Sleep disturbance in euthymic bipolar patients.
J. Psychopharmacol. (Oxford)., Aug;26(8):1108-12 (2012)
Pharmacogenetic investigation of response to duloxetine treatment in generalized anxiety disorder.
Proposed DSM-5 mixed features are associated with greater likelihood of remission in out-patients with major depressive disorder.
Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants.
BMJ Open., 2(2):e000544 (2012)
Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: A diffusion tensor imaging study using legacy data.
Personality and bipolar disorder: dissecting state and trait associations between mood and personality.
Psychol Med., Aug;41(8):1593-604 (2011)
Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model.
Psychol Med., Jan;42(1):41-50 (2012)
Low-dose transdermal testosterone augmentation therapy improves depression severity in women.
CNS Spectr., Dec;14(12):688-94 (2009)
Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.
Neuropsychopharmacology., Jun;34(7):1819-28 (2009)
Effective agents in treating mania.
J Clin Psychiatry., Apr;70(4):e08 (2009)
A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder.
Am J Psychiatry., Jun;166(6):718-25 (2009)
Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Am J Psychiatry., Mar;167(3):289-97 (2010)
Clinical decision making in the treatment of mania.
J Clin Psychiatry., 69 Suppl 5:16-21 (2008)
Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial.
Psychopharmacol Bull., 41(1):34-45 (2008)
Association of a polymorphism near CREB1 with differential aversion processing in the insula of healthy participants.
Arch. Gen. Psychiatry., Aug;65(8):882-92 (2008)
Pharmacogenetics, race, and psychiatry: prospects and challenges.
Harv Rev Psychiatry., 14(2):92-108 (2006)